Previous close | 0.2500 |
Open | 0.2500 |
Bid | 0.0000 |
Ask | 0.3500 |
Strike | 4.00 |
Expiry date | 2024-09-20 |
Day's range | 0.2500 - 0.2500 |
Contract range | N/A |
Volume | |
Open interest | 462 |
Improved Financial Metrics and Strategic Partnerships Mark the Quarter
Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three months ended March 31, 2024 and highlighted recent corporate updates.
Alpine Immune Sciences (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.